Lui VWY - Search Results

1

Translational genomics of nasopharyngeal cancer.

Tsang CM, Lui VWY, Bruce JP, Pugh TJ, Lo KW. Tsang CM, et al. Among authors: lui vwy. Semin Cancer Biol. 2020 Apr;61:84-100. doi: 10.1016/j.semcancer.2019.09.006. Epub 2019 Sep 12. Semin Cancer Biol. 2020. PMID: 31521748 Free article. Review.

2

A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells.

Wong JH, Lui VW, Umezawa K, Ho Y, Wong EY, Ng MH, Cheng SH, Tsang CM, Tsao SW, Chan AT. Wong JH, et al. Cancer Lett. 2010 Jan 1;287(1):23-32. doi: 10.1016/j.canlet.2009.05.022. Epub 2009 Jun 26. Cancer Lett. 2010. PMID: 19560263

3

STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.

Lui VW, Wong EY, Ho Y, Hong B, Wong SC, Tao Q, Choi GC, Au TC, Ho K, Yau DM, Ma BB, Hui EP, Chan AS, Tsang CM, Tsao SW, Grandis JR, Chan AT. Lui VW, et al. Int J Cancer. 2009 Oct 15;125(8):1884-93. doi: 10.1002/ijc.24567. Int J Cancer. 2009. PMID: 19588483 Free article.

4

An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation.

Lui VW, Lau CP, Cheung CS, Ho K, Ng MH, Cheng SH, Hong B, Tsao SW, Tsang CM, Lei KI, Yamasaki Y, Mita A, Chan AT. Lui VW, et al. Biochem Pharmacol. 2010 Jun 15;79(12):1772-80. doi: 10.1016/j.bcp.2010.02.012. Epub 2010 Feb 26. Biochem Pharmacol. 2010. PMID: 20219441

5

Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells.

Lui VW, Lau CP, Ho K, Ng MH, Cheng SH, Tsao SW, Tsang CM, Lei KI, Chan AT, Mok TS. Lui VW, et al. Invest New Drugs. 2011 Dec;29(6):1241-52. doi: 10.1007/s10637-010-9470-y. Epub 2010 Jun 23. Invest New Drugs. 2011. PMID: 20571878

6

K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.

Ng YK, Wong EY, Lau CP, Chan JP, Wong SC, Chan AS, Kwan MP, Tsao SW, Tsang CM, Lai PB, Chan AT, Lui VW. Ng YK, et al. Invest New Drugs. 2012 Feb;30(1):48-58. doi: 10.1007/s10637-010-9513-4. Epub 2010 Aug 7. Invest New Drugs. 2012. PMID: 20694504

7

Targeting tumor hypoxia in nasopharyngeal carcinoma.

Hong B, Lui VW, Hashiguchi M, Hui EP, Chan AT. Hong B, et al. Head Neck. 2013 Jan;35(1):133-45. doi: 10.1002/hed.21877. Epub 2011 Nov 22. Head Neck. 2013. PMID: 22106024 Review.

8

Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells.

Tsang CM, Yip YL, Lo KW, Deng W, To KF, Hau PM, Lau VM, Takada K, Lui VW, Lung ML, Chen H, Zeng M, Middeldorp JM, Cheung AL, Tsao SW. Tsang CM, et al. Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):E3473-82. doi: 10.1073/pnas.1202637109. Epub 2012 Nov 16. Proc Natl Acad Sci U S A. 2012. PMID: 23161911 Free PMC article.

9

STAT3 as a therapeutic target for Epstein-Barr virus (EBV): associated nasopharyngeal carcinoma.

Ho Y, Tsao SW, Zeng M, Lui VW. Ho Y, et al. Cancer Lett. 2013 Apr 28;330(2):141-9. doi: 10.1016/j.canlet.2012.11.052. Epub 2012 Dec 6. Cancer Lett. 2013. PMID: 23220625 Review.

10

Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells.

Zhang G, Tsang CM, Deng W, Yip YL, Lui VW, Wong SC, Cheung AL, Hau PM, Zeng M, Lung ML, Chen H, Lo KW, Takada K, Tsao SW. Zhang G, et al. PLoS One. 2013 May 1;8(5):e62284. doi: 10.1371/journal.pone.0062284. Print 2013. PLoS One. 2013. PMID: 23658720 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page